Literature DB >> 7900095

Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury.

A Kashyap1, A Blinc, V J Marder, D P Penney, C W Francis.   

Abstract

High frequency ultrasound has been previously shown to accelerate fibrinolysis in vitro at intensities that are potentially applicable for noninvasive administration clinically. To extend these findings in vivo, we have investigated the effects of ultrasound on fibrinolysis induced by streptokinase in a rabbit model of small vessel injury. Full thickness puncture wounds were made in rabbit ears with a scalpel blade. The rabbits were rested for 2-3 hours after cessation of bleeding to allow maturation of hemostatic plugs. Saline or streptokinase was then infused intravenously, and ultrasound was applied to some lesions at 1 MHz with a 50% duty cycle at 1 W/cm2 net intensity. Ear lesions in rabbits treated with saline showed no bleeding after 30 minutes whether they were exposed to ultrasound or not. Streptokinase alone induced bleeding after 19.7 +/- 5.5 minutes. Application of ultrasound significantly reduced the time to bleeding in streptokinase treated rabbits to 7.5 +/- 3.9 minutes (p < .002). The times to bleeding with "sham" ultrasound (18.8 +/- 5.6 minutes) and heating of the ear (18.0 +/- 5.6 minutes) during streptokinase administration were not significantly different compared to streptokinase alone. Histologic examination revealed that application of ultrasound resulted in a mild increase in interstitial edema and accumulation of polymorphonuclear leukocytes but did not cause vascular or other tissue damage. We conclude that the noninvasive, percutaneous application of ultrasound significantly accelerated streptokinase-induced fibrinolysis in this rabbit model of small vessel injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900095     DOI: 10.1016/0049-3848(95)90179-j

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Correlation of cavitation with ultrasound enhancement of thrombolysis.

Authors:  Saurabh Datta; Constantin-C Coussios; Louis E McAdory; Jun Tan; Tyrone Porter; Gabrielle De Courten-Myers; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2006-08       Impact factor: 2.998

2.  Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.

Authors:  David W Newell; M Mohsin Shah; Robert Wilcox; Douglas R Hansmann; Erik Melnychuk; John Muschelli; Daniel F Hanley
Journal:  J Neurosurg       Date:  2011-06-10       Impact factor: 5.115

3.  Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots.

Authors:  I N Chernysh; C E Everbach; P K Purohit; J W Weisel
Journal:  J Thromb Haemost       Date:  2015-03-13       Impact factor: 5.824

4.  Safety Evaluation of a Forward-Viewing Intravascular Transducer for Sonothrombolysis: An in Vitro and ex Vivo Study.

Authors:  Leela Goel; Huaiyu Wu; Bohua Zhang; Jinwook Kim; Paul A Dayton; Zhen Xu; Xiaoning Jiang
Journal:  Ultrasound Med Biol       Date:  2021-08-23       Impact factor: 2.998

5.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

6.  Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model.

Authors:  Victor Frenkel; Jay Oberoi; Michael J Stone; Melissa Park; Cheri Deng; Bradford J Wood; Ziv Neeman; McDonald Horne; King C P Li
Journal:  Radiology       Date:  2006-02-21       Impact factor: 11.105

7.  Can pulsed ultrasound increase tissue damage during ischemia? A study of the effects of ultrasound on infarcted and non-infarcted myocardium in anesthetized pigs.

Authors:  Göran K Olivecrona; Bjarne Madsen Härdig; Anders Roijer; Mattias Block; Edgars Grins; Hans W Persson; Leif Johansson; Bertil Olsson
Journal:  BMC Cardiovasc Disord       Date:  2005-04-15       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.